Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new entry states 'No longer looking for participants', indicating a recruitment status change. The history also adds a new revision label 'Revision: v3.6.0' and removes the previous 'Revision: v3.5.5' entry.SummaryDifference0.4%

- Check16 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history and the previous revision (v3.5.4) was removed from the list, indicating an update to the record's version history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history shows a new revision (v3.5.4) superseding the previous one (v3.5.3), indicating a small update to the study page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer/site build revision was updated from “v3.5.2” to “v3.5.3,” reflecting a backend or interface version change rather than an update to the trial record itself.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check95 days agoChange DetectedThe Record History gained new entries for Contacts/Locations and Study Status, with revision v3.5.0 released on 2026-03-18. The 2025-11-21 entry and revision v3.4.3 were removed.SummaryDifference0.6%

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.